Search results :

Revasc

More information: STITCH, PubChem and possibly Wikipedia

ATC Code: B01AE01

Side effects

Options: Hide MedDRA Preferred Terms

MedDRA Preferred Term Side effect Data for drug Placebo Labels
1 2 3
Wound secretion Wound secretion common, 0.676% - 6.39% x x x
Injection site mass Injection site mass 0.676% - 6.39% x x x
Anaemia Anaemia 0.676% - 6.39% x x x
Haemorrhage Haemorrhage postmarketing, 2.03% - 33% x x
Major bleed 0% - 0.833% x x
Haemoglobin Haemorrhage postmarketing, 2.03% - 33% x x
Thrombophlebitis Thrombophlebitis 0.676% - 8.18% x x x
Nausea Nausea 0.676% - 6.39% x x x
Impaired healing Impaired healing uncommon x x x
Anaphylactic shock Anaphylactoid reaction postmarketing x x x
Anaphylactoid reaction Anaphylactoid reaction postmarketing x x x
Burkitt's lymphoma Burkitt's lymphoma x x
Cerebrovascular disorder Cerebrovascular disorder x x
Chest pain Chest pain x
Infection Infection x
Confusional state Confusional state x
Feeling abnormal Confusional state x
Constipation Constipation x
Cystitis Cystitis x
Bladder pain Cystitis x
Cystitis noninfective Cystitis x
Joint dislocation Joint dislocation x
Dizziness Dizziness x x x
Dyspnoea Dyspnoea x
Oedema Oedema x
Epistaxis Epistaxis x x x
Dermatitis Rash x
Rash Rash x
Body temperature increased Body temperature increased x x x
Gastrointestinal disorder Gastrointestinal disorder x
Haematemesis Haematemesis x x x
Haematoma Haematoma x x x
Haematuria Haematuria x x x
Hypersensitivity Hypersensitivity x x x
Hypertension Hypertension x
Hypokalaemia Hypokalaemia x
Hypotension Hypotension x x x
Immune system disorder Immune system disorder x
Pain in extremity Leg pain x x
Mediastinal disorder Mediastinal disorder x
Nervous system disorder Nervous system disorder x
Oliguria Oliguria x
Pain Pain x
Shock Shock x
Thrombosis Thrombosis x x
Urinary tract infection Urinary tract infection x
Urethral disorder Urinary tract disorder x
Urinary tract disorder Urinary tract disorder x
Urticaria Urticaria x
Angiopathy Angiopathy x
Vomiting Vomiting x x x
Urinary retention Urinary retention x
Haemoglobin decreased Haemoglobin decreased x x
Malnutrition Malnutrition x
Skin disorder Unspecified disorder of skin and subcutaneous tissue x
Oedema peripheral Leg edema x x
Hyperpyrexia Hyperpyrexia x
Infestation Infestation NOS x
Insomnia Insomnia x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

DESIRUDIN

Side effects:24
Source:FDA Structured Product Label

DESIRUDIN RECOMBINANT / IPRIVASK

Side effects:24
Source:FDA

desirudin / desirudin

Side effects:44
Source:EMA

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label